Filter Search


Healthcare and Medical


Location Summary Deadline
Japan Endoscopic Equipment Sales Contract 2026-04-06
Paraguay Acquisition Of Technological Equipment For Community Mental Health And Addictions, Ambulatory Health Care Services And Addictions And Psychiatric International Units In General Hospitals 2026-04-06
Canada Notice Of Intention To Use Canoe Procurement Group Of Canada Program 2026-04-06
Germany Conclusion Not Excluding Drug Discount Agreement. According To Section 130a Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Golimumab (atc Code According To Who: L04ab06) 2026-04-06
Germany Conclusion Not Excluding Drug Discount Agreement. According To Section 130a Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Leuprorelin (atc Code According To Who: L02ae02) 2026-04-06
Germany The Tender Involves The Conclusion Of Non-exclusive Discount Agreements For The Active Ingredient Tocilizumab Under An Open-house Model, As Per § 130a Abs. 8 Sgb V. Tocilizumab 2026-04-06
Germany The Tender Involves The Conclusion Of Non-exclusive Discount Agreements For Pharmaceuticals Under An Open-house Model For The Active Ingredient Flecainide. Flecainide 2026-04-06
Bulgaria Delivery Of Orthopedic Implants And Osteosynthesis Necessary For The Activity Of The Orthopedics And Traumatology Clinic At The University Hospital Prof. Dr. Stoyan Kirkovich Ad. 2026-04-07
Netherlands Market Consultation Umc Utrect Regarding Ct Scanners 2026-04-07
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130a Paragraph. 8 Sgb V On The Active Ingredients Mentioned With The Possibility Of Contracting Within The Framework Of The So-called Openhouse Procedure. 2026-04-07
Whats app